PCSK9 and familial hyperaldosteronism: The most common variants involve mutations of the LDLR gene—estimated to account for >80% of FH cases—followed by mutations of the apolipoprotein B-100 (APOB) and proprotein convertase subtulisin/kexin type 9 (PCSK9) genes.